Company News from the May 6th MM&M News Brief
Kos Pharmaceuticals bought Teveten and Teveten HCT and the U.S. commercial rights to Cardizem LA from Biovail Corp. for ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.